Bibliography
- AUTRAN B, CARCELAIN G, LI TS et al.: Positive effects of combined antiretroviral therapy on CD4+ T cell homeostasis and function in advanced HIV disease. Science (1997) 277:112-116.
- KELLEHER AD, CARR A, ZAUNDERS J, COOPER DA: Alterations of the immune response of HIV-infected subjects treated with an HIV-specific protease inhibitor, ritonavir. J. Infect. Dis. (1996) 173:321-329.
- ANGEL JB, KUMAR A, PARATO K et al.: Improvement in cell-mediated immune function, during potent anti-human immunodeficiency virus therapy with ritonavir plus saquinavir. J. Infect. Dis. (1998) 177:898-904.
- APPAY V, NIXON DF, DONAHOE SM et al.: HIV-specific CD8+ T cells produce antiviral cytokines but are impaired in cytolitic function. J. Exp. Med. (2000) 192:63-75.
- GOROCHOV G, NEUMANN AU, PARIZOT C et al.: Down-regulation of CD8+ T cell-expansions in patients with HIV infection receiving highly active combination therapy. Blood (2001) 97:1787-1795.
- TRABATTONI D, PICONI S, BIASIN M et al.: Granule-dependent mechanisms of lysis are defective in CD8+ T cells of HIV-infected, antiviral therapy-treated individuals. AIDS (2004) 18:859-869.
- CLERICI M, SHEARER GM: Is HIV infection associated with a TH1→ TH2 switch? Trends Immunol. (formerly Immunol. Today) (1993) 14:107-111.
- KOVACS JA, LEMPICKI RA, SIDOROV IA et al.: Induction of prolonged survival of CD4+ T lymphocytes by intermittent IL-2 therapy in HIV-infected patients. J. Clin. Invest. (2005) 115:2139-2148.
- LEVY Y, GAHERY-SEGARD H, DURIER C et al.: Immunological and virological efficacy of a therapeutic immunization combined with interleukin-2 in chronically HIV-1 infected patients. AIDS (2005) 19:279-86.
- LICHTENSTEIN KA, ARMON C, MOORMAN AC, WOOD KC, HOLMBERG SD: A 7-year longitudinal analysis of IL-2 in patients treated with highly active antiretroviral therapy. AIDS (2004) 19(18):2346-2348.
- ARDUINO RC, NANNINI EC, RODRIGUEZ-BARRADAS M et al.: Evaluation of Subcutaneous Proleukin in a Randomized International Trial (ESPRIT) Vanguard Group; ESPRIT Executive Committee. CD4 cell response to 3 doses of subcutaneous interleukin 2: meta-analysis of 3 Vanguard studies. Clin. Infect. Dis. (2001) 39:115-122.
- MARCHETTI G, MERONI L, MOLTENI C et al.: Interleukin-2 immunotherapy exerts a differential effect on CD4 and CD8 T cell dynamics. AIDS (2004) 18:211-216.
- SERETI I, IMAMICHI H, NATARAJAN V et al.: In vivo expansion of CD4CD45RO-CD25 T cells expressing foxP3 in IL-2-treated HIV-infected patients. J. Clin. Invest. (2005) 115:1839-1847.
- CLERICI M, LUCEY DR, PINTO LA et al.: Restoration of HIV-specific cell mediated immune responses by interleukin-12 in vitro. Science (1993) 262:1721-1724.
- MASTROIANNI CM, D’ETTORRE G, FORCINA G, VULLO V: Teaching tired T cells to fight HIV: time to test IL-15 for immunotherapy? Trends Immunol. (2004) 25:121-125.
- HASSAN J, REEN DJ: IL-7 promotes the survival and maturation but not differentiation of human post-thymic CD4+ T cells. Eur. J. Immunol. (1998) 28:3057-3065.
- AKASHI K, KONDO M, WEISSMAN IL et al.: Role of interleukin-7 in T-cell development from hematopoietic stem cells. Immunol. Rev. (1998) 165:13-28.
- FRY TJ, CONNICK E, FALLOON J. et al.: A potential role for interleukin-7 in T-cell homeostasis. Blood (2001) 97:2983-2990.
- RHODES J, CHEN H, HALL SR et al., Therapeutic potentiation of the immune system by costimulatory Schiff-base-forming drugs. Nature (1995) 377:71-75.
- GORI A, TRABATTONI T, BANDERA A et al.: Immunomodulation induced by tucaresol in HIV-infection: results of a 16 weeks pilot Phase I/II trial. Antivir. Ther. (2004) 9:603-614.
- AUTRAN B, COSTAGLIOLA D, MURPHY R, KATLAMA C: Evaluating therapeutic vaccines in patients infected with HIV. Expert Rev. Vaccines (2004) 3:S169-S177.
- WAHREN B, LIU M: Therapeutic vaccination against HIV. Expert Rev. Vaccines (2004) 3:S179-S188.
- DORRELL L: Therapeutic immunization strategies for the control of HIV-1. Expert Rev. Vaccines (2005) 4:513-520.
Websites
- http://AIDSinfo.nih.gov The panel on clinical practices for treatment of HIV infection. Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents.
- http://clinicaltrials.gov/ct/show/NCT00115960?order=1 National Institute Of Allergy And Infectious Diseases: safety of and immune response to an HIV preventive vaccine (HIV-1 gag DNA alone or with IL-15 DNA) given with or without three different booster vaccinations in HIV uninfected adults. NCT00115960.
- http://clinicaltrials.gov/ct/show/NCT00105417?order=1 National Institute Of Allergy And Infectious Diseases: IL-7 to treat HIV-infected people receiving antiretroviral treatment. NCT00105417.